Publishers Fight Open Access Bill

The Federal Research Public Access Act faces stiff opposition from the Association American of Publishers.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The US Capitol BuildingWIKIMEDIA COMMONS, KMCCOY

Dozens of scholarly journal publishers have voiced their opposition to an open access bill in the US Congress. The bill, called the Federal Research Public Access Act (FRPAA), would require any research supported by federal money to be deposited in a publicly accessible online repository within 6 months of publication.

The 81 signatories of letters, drafted and sent to the House of Representatives and Senate by the Association of American Publishers (AAP), included multi-title publishing giants, such as Elsevier, the American Chemical Society, and Springer Publishing Company, along with small society and association publishers, such as the American Fisheries Society and the American Association of Immunologists.

"FRPAA is little more than an attempt at intellectual eminent domain, but without fair compensation to authors and publishers," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours